Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial

Eccles, Ronald ORCID: https://orcid.org/0000-0001-9492-2062, Winther, B., Johnston, S. L., Robinson, P., Trampisch, M. and Koelsch, S. 2015. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial. Respiratory Research 16 , 121. 10.1186/s12931-015-0281-8

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (936kB) | Preview

Abstract

Iota-carrageenan (I-C) is active against respiratory viruses in vitro and was effective as nasal spray in three previous clinical trials. The current trial served to further investigate I-C in patients with early common cold symptoms.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Publisher:	BioMed Central
ISSN:	1465-993X
Date of First Compliant Deposit:	30 March 2016
Date of Acceptance:	18 September 2015
Last Modified:	06 May 2023 04:43
URI:	https://orca.cardiff.ac.uk/id/eprint/80158

Citation Data

Cited 59 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item